Table 1.

List of FDA-approved gadolinium-based contrast agents

Brand name	Chemical name	Structure	FDA indicated to visualize
Linear
Omniscan®	Gadodiamide	Non-ionic	Lesions with abnormal vascularity in the brain, spine, thoracic, abdominal, pelvic cavities, and the retroperitoneal space
Magnevist®	Gadopentetate	Ionic	Lesions and abnormal vascularity in the central nervous system, extracranial/extraspinal tissues, head, neck, and body
MultiHance®	Gadobenate	Ionic	Lesions with abnormal blood–brain barrier or abnormal vascularity of the brain, spine, and associated tissues
Eovist®	Gadoxetate	Non-ionic	Lesions in adults with known or suspected focal liver disease
Macrocyclic
ProHance ®	Gadoteridol	Non-ionic	Abnormal vascularity in the brain (intracranial lesions), spine, head, neck, and associated tissues
Gadavist ®	Gadobutrol	Non-ionic	Areas with disrupted blood–brain barrier and/or abnormal vascularity of the central nervous system; presence and extent of malignant breast disease; known or suspected supra-aortic or renal artery disease
Dotarem ®	Gadoterate	Ionic	Areas with disruption of the blood–brain barrier (BBB) and/or abnormal vascularity in the brain (intracranial), spine, and associated tissues